SCHEMBL2709235

SCHEMBL2709235

COc1c(F)c(F)c(-c2c3ccccc3c(-c3cc(F)c(F)c(F)c3)c3ccccc23)c(F)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TUBB1 Q9H4B7 7/20 0.34
TUBB4A P04350 6/20 0.34
TUBB P07437 6/20 0.34
TUBA3C P0DPH7 6/20 0.34
TUBA1B P68363 6/20 0.34
TUBA4A P68366 6/20 0.34
TUBB4B P68371 6/20 0.34
TUBB3 Q13509 6/20 0.34
TUBB2A Q13885 6/20 0.34
TUBB8 Q3ZCM7 6/20 0.34
TUBA3E Q6PEY2 6/20 0.34
TUBA1A Q71U36 6/20 0.34
TUBA1C Q9BQE3 6/20 0.34
TUBB6 Q9BUF5 6/20 0.34
TUBB2B Q9BVA1 6/20 0.34
L3MBTL1 Q9Y468 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2709695 0.95 KDM4E (0.36) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB1
SCHEMBL2709446 0.92 TUBB4A (0.40) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB1
SCHEMBL12086077 0.92 TUBB4A (0.40) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB1
SCHEMBL12086025 0.89 TUBB4A (0.35) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB1
SCHEMBL2725991 0.89 TUBB4A (0.35) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB1
SCHEMBL2713032 0.88 KDM4E (0.43) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB1
SCHEMBL2726738 0.88 KDM4E (0.35) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB1
SCHEMBL2726648 0.88 KDM4E (0.35) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB1
SCHEMBL2727807 0.88 L3MBTL1 (0.38) KDM4EALDH1A1MAPK1SMN1; SMN2TUBB1
SCHEMBL2731612 0.86 KDM4E (0.52) KDM4EALDH1A1MAPK1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 KDM4E 670/4885ALDH1A1 34/4885MAPK1 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.